Cetera Advisors’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History
Bought
Maintained
Sold
Other funds holding BTAL
BCM
TWM
FGA
CWG
EFG
PFA
APA
Cetera Advisors's BTAL Position: Q1 2023 in Review
Cetera Advisors sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q1 2023, closing a stake of 26,256 shares — an estimated $557K sold.
Cetera Advisors first reported a position in BTAL in Q3 2022 and held it in 2 quarters. The position peaked at $557K in Q4 2022. 89 funds tracked by Wall St. Rank hold BTAL as of Q1 2023.
- Cetera Advisors reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q1 2023 after selling out during the quarter.
- Cetera Advisors sold 26,256 AGF US Market Neutral Anti-Beta Fund shares in Q1 2023, an estimated $557K.
- Cetera Advisors first reported a position in AGF US Market Neutral Anti-Beta Fund in Q3 2022 and held it in 2 quarters.
- Cetera Advisors's AGF US Market Neutral Anti-Beta Fund position peaked at $557K in Q4 2022.
- 89 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q1 2023.
Based on Cetera Advisors's 13F filing for Q1 2023, filed 15 May 2023.